Cargando…
Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis
BACKGROUND: Juvenile idiopathic arthritis (JIA) is common and difficult to treat. Cannabidiol (CBD) is now widely available, but no studies to date have investigated the use of CBD for JIA. METHODS: We performed a chart review to identify patients with JIA at a Midwestern medical institution between...
Autores principales: | Failing, Christopher J, Boehnke, Kevin F., Riebschleger, Meredith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670290/ https://www.ncbi.nlm.nih.gov/pubmed/34903213 http://dx.doi.org/10.1186/s12969-021-00656-5 |
Ejemplares similares
-
Patient characteristics associated with response to NSAID monotherapy in children with systemic juvenile idiopathic arthritis
por: Sura, Anjali, et al.
Publicado: (2018) -
Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)
por: Boehnke, Kevin F., et al.
Publicado: (2022) -
Efficacy of non-steroidal anti-inflammatory drug monotherapy in children with systemic juvenile idiopathic arthritis
por: Riebschleger, Meredith P, et al.
Publicado: (2012) -
Prescription patterns for children with juvenile idiopathic arthritis in Michigan Medicaid: a comparison by prescriber type
por: Riebschleger, Meredith P, et al.
Publicado: (2014) -
The use of cannabidiol (CBD) as an analgesic component
por: Petersen, Kristian Kjær-Staal, et al.
Publicado: (2023)